Use of a spectrophotometric hemoglobin assay to objectively quantify intracerebral hemorrhage in mice

Stroke

Volumn 28, Issue 11, 1997, Pages 2296-2302

  Choudhri, Tanvir F ^b   Hoh, Brian L ^b   Solomon, Robert A ^b   Connolly Jr , E Sander ^b   Pinsky, David J ^a,b  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b Department of Medicine ^*

Author keywords

Anticoagulants; Intracerebral hemorrhage; Mice; Plasminogen activator; Tissue type

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTICLE; BLOOD CLOT LYSIS; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; HEMOGLOBIN DETERMINATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RELIABILITY; SPECTROPHOTOMETRY; STEREOTAXIS;

EID: 0030710120     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.11.2296     Document Type: Article

References (38)

1. Slivka A, Levy D. Natural history of progressive ischemic stroke in a population treated with heparin. Stroke. 1990;21:1657-1662.
2. Babikian VL, Kase CS, Pessin MS, Norrving B, Gorelick PB. Intracerebral hemorrhage in stroke patients anticoagulated with heparin. Stroke. 1989;20:1500-1503.
3. Ramirez-Lassepas M, Quinones MR, Nino HH. Treatment of acute ischemic stroke: open trial with continuous intravenous heparinization. Arch Neurol. 1986;43:386-390.
4. Duke RJ, Bloch RF, Turpie AG, Trebilcock R, Bayer N. Intravenous heparin for the prevention of stroke progression in acute partial stable stroke. Ann Intern Med. 1986;105:825-828.
5. Meyer JS, Gilroy J, Barnhart MI, Johnson JF. Therapeutic thrombolysis in cerebral thromboembolism. Neurology. 1963;13: 927-937.
6. Meyer JS, Gilroy J, Barnhart MI, Johnson JF. Anticoagulants plus streptokinase therapy in progressive stroke. JAMA. 1964;189:373.
7. Hommel M, Cornu C, Boutitie F, Boissel JP, for the MultiCenter Acute Stroke Trial-Europe Study Group. Thrombolytic therapy with streptokinase in acute ischemic stroke. N Engl J Med. 1996; 335:145-150.
8. Wardlaw JM, Warlow CP. Thrombolysis in acute ischemic stroke: does it work? Stroke. 1992;23:1826-1839.
9. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
10. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-1025.
11. Trouillas P, Nighoghossian N, Getenet JC, Riche G, Neuschwander P, Froment JC, Turjman F, Jin JX, Malicier D, Fournier G, Gabry AL, Ledoux X, Derex L, Berthezene Y, Adeleine P, Xie J, Ffrench P, Dechavanne M. Open trial of intravenous tissue plasminogen activator in acute carotid territory stroke. Stroke. 1996;27:882-890.
12. Haley EC Jr, Levy DE, Brott TG, Sheppard GL, Wong MC, Kongable GL, Torner JC, Marler JR. Urgent therapy for stroke, part II: pilot study of tissue plasminogen activator administered 91-180 minutes from onset. Stroke. 1992;23:641-645.
13. Hacke W, Kaste M, Fieschi C, Toni D. Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-1025.
14. Brott TG, Haley EC Jr, Levy DE, Barsan W, Broderick J, Sheppard GL, Spilker J, Kongable GL, Massey S, Reed R. Marier JR. Urgent therapy for stroke, part I: pilot study of tissue plasminogen activator administered within 90 minutes. Stroke. 1992;23:632-640.
15. del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM. Furlan AJ, Ferbert A, Alberts MJ, Zivin JA, Wechsler L, Busse O, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol. 1992;32:78-86.
16. de Courten-Myers GM, Kleinholz M, Holm P, DeVoe G, Schmitt G, Wagner KR, Myers RE. Hemorrhagic infarct conversion in experimental stroke. Ann Emerg Med. 1992;21:120-126.
17. Overgaard K, Sereghy T, Pedersen H, Boysen G. Neuroprotection with NBQX and thrombolysis with rt-PA in rat embolic stroke. Neurol Res. 1993;15:344-349.
18. Overgaard K, Sereghy T, Boysen G, Pedersen H, Diemer NH. Reduction of infarct volume by thrombolysis with rt-PA in an embolic rat stroke model. Scand J Clin Lab Invest. 1993;53:383-393.
19. Benes V, Zabramski JM, Boston M, Puca A, Spetzler RF. Effect of intra-arterial tissue plasminogen activator and urokinase on autologous arterial emboli in the cerebral circulation of rabbits. Stroke. 1990;21:1594-1599.
20. Overgaard K, Sereghy T, Pedersen H, Boysen G. Effect of delayed thrombolysis with rt-PA in a rat embolic stroke model. J Cereb Blood Flow Metab. 1994;14:472-477.
21. Lyden PD, Zivin JA, Clark WA, Madden K, Sasse KC, Mazzarella VA, Terry RD, Press GA. Tissue plasminogen activator-mediated thrombolysis of cerebral emboli and its effect on hemorrhagic infarction in rabbits. Neurology. 1989;39:703-708.
22. Kochanek PM, Dutka AJ, Kumaroo KK, Hallenbeck JM. Effects of prostacyclin, indomethacin, and heparin on cerebral blood flow and platelet adhesion after multifocal ischemia of canine brain. Stroke. 1988;19:693-699.
23. Slivka A, Pulsinelli W. Hemorrhagic complications of thrombolytic therapy in experimental stroke. Stroke. 1987;18:1148-1156.
24. Lyden PD, Zivin JA, Soll M, Sitzer M, Rothrock JF, Alksne J. Intracerebral hemorrhage after experimental embolic infarction: anticoagulation. Arch Neurol. 1987;44:848-850.
25. Van Kampen EJ, Zijlstra WG. Standardization of hemoglobinometry, II: the hemiglobincyanide method. Clin Chim Acta. 1961; 6:538-544.
26. Rosenberg GA, Mun-Bryce S, Wesley M, Kornfield M. Collagenase-induced intracerebral hemorrhage in rats. Stroke. 1990;21: 801-807.
27. Connolly ESJr, Winfree CJ, Stern DM, Solomon RA, Pinsky DJ. Procedural and strain-related variables significantly affect outcome in a murine model of focal cerebral ischemia. Neurosurgy. 1996;38: 523-532.
28. Connolly ES Jr, Winfree CJ, Springer TA, Naka Y, Liao H, Yan SD, Stern DM, Solomon RA, Gutierrez-Ramos J-C, Pinsky DJ. Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion: role of neutrophil adhesion in the pathogenesis of stroke. J Clin Invest. 1996;97:209-216.
29. Bederson JB, Pitts LH, Nishimura MC, Davis RL, Bartkowski HM. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 1986;17:1304-1308.
30. Lee KR, Colon GP, Betz AL, Keep RF, Kim S, Hoff JT. Edema from intracerebral hemorrhage: the role of thrombin. J Neurosurg. 1996;84:91-96.
31. Del Bigio MR, Yan HJ, Buist R, Peeling J. Experimental intracerebral hemorrhage in rats: magnetic resonance imaging and histopathological correlates. Stroke. 1996;27:2312-2320.
32. Qian L, Nagaoka T, Ohno K, Tominaga B, Nariai T, Hirakawa K, Kuroiwa T, Takakuda K, Miyairi H. Magnetic resonance imaging and pathologic studies on lateral fluid percussion injury as a model of focal brain injury in rats. Bull Tokyo Med Dent Univ. 1996;43:53-66.
33. Brown MS, Kornfeld M, Mun-Bryce S, Sibbitt RR, Rosenberg GA. Comparison of magnetic resonance imaging and histology in collagenase-induced hemorrhage in the rat. J Neuroimaging. 1995;5:23-33.
34. Thulborn KR, Sorensen AG, Kowall NW, McKee A, Lai A, McKinstry RC, Moore J, Rosen BR, Brady TJ. The role of ferritin and hemosiderin in the MR appearance of cerebral hemorrhage: a histopathologic biochemical study in rats. AJR Am J Neuroradiol. 1990;11:291-297.
35. Elger B, Seega J, Brendel R. Magnetic resonance imaging study on the effect of levemopamil on the size of intracerebral hemorrhage in rats. Stroke. 1994;25:1836-1841.
36. Weingarten K, Zimmerman RD, Deo-Narine V, Markisz J, Cahill PT, Deck MD. MR imaging of acute intracranial hemorrhage: findings on sequential spin-echo and gradient-echo images in a dog model. AJR Am J Neuroradiol. 1991;12:457-467.
37. Drabkin DL, Austin JH. Spectrophotometric studies, II: preparations from washed blood cells; nitric oxide hemoglobin and sulfhemoglobin. J Biol Chem. 1935;112:51-65.
38. Drabkin DL, Austin JH. Spectrophotometric studies, IV: hemochromogens. J Biol Chem. 1935;112:89-104